The risks of medical innovation : risk perception and assessment in historical context
Author(s)
Bibliographic Information
The risks of medical innovation : risk perception and assessment in historical context
(Studies in the social history of medicine, 21)
Routledge, 2014, c2006
- : pbk
Available at 1 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
"First published 2006, ... first issued in paperback 2014"--T.p. verso
Includes indexes
Description and Table of Contents
Description
The risks involved in introducing new drugs and devices are amongst the most discussed issues of modern medicine.
Presenting a new way of thinking about these issues, this volume considers risk and medical innovation from a social historical perspective, and studies specific cases of medical innovation, including X-rays, the pill and Thalidomide, in their respective contexts.
International cases are examined through the lens of a particular set of shared questions - highlighting differences, similarities, continuities and changes, and offering a historical sociology of risk. Particularly important is the re-conceptualization of dangers in terms of risk - a numerical and probabilistic approach allowing for seemingly objective and value-neutral decisions.
Read together, these papers add to our understanding of the current debate about risk and safety by providing a comparative background to the discussion, as well as a set of generally applicable criteria for analyzing and evaluating the contemporary issues surrounding medical innovation.
Table of Contents
Preface. Risk and Medical Innovation: A Historical Perspective. To Assess and to Improve: Practitioners? Approaches to Doubts Linked with Medical Innovations 1720-1920. Anaesthesia and the Evaluation of Surgical Risk in Mid-Nineteenth Century Britain. Redemption, Danger, and Risk: The History of Anti-Bacterial Chemotherapy and the Transformation of Tuberculin. As Safe as Milk or Sugar Water?: Perceptions of Risks and Benefits of the BCG Vaccine in the 1920s and 1930s in France and Germany. From Danger to Risk: The Perception and Regulation of X-Rays in Switzerland 1896-1970. The Population as Patient: Alice Stewart and the Controversy over Low-Level Radiation in the 1950s. To Treat or Not to Treat: Drug Research and the Changing Nature of Essential Hypertension. Hormones at Risk: Cancer and the Medical Uses of Industrially-Produced. Sex Steroids in Germany, 1930-1960. Assessment and Medical Authority in Operative Fracture Care in the 1960 and 1970s. Assessing the Risk and Safety of the Pill: Maternal Mortality and the Pill. Addressing Uncertainties: The Conceptualisation of Brain Death in Switzerland 1960-2000. Risk on Trial. The Interaction of Innovation and Risk in Cancer Clinical Trials. BioRisk: Interleukin-2 from Laboratory to Market in the United States and Germany. The Redemption of Thalidomide: Standardizing the Risk of Birth Defects
by "Nielsen BookData"